Janet Dorling - Net Worth and Insider Trading

Janet Dorling Net Worth

The estimated net worth of Janet Dorling is at least $7,118 dollars as of 2024-11-28. Janet Dorling is the Chief Commercial Officer of Achaogen Inc and owns about 284,738 shares of Achaogen Inc (AKAOQ) stock worth over $7,118. Janet Dorling is also the Director of CymaBay Therapeutics Inc and owns about 0 shares of CymaBay Therapeutics Inc (CBAY) stock worth over $0. Details can be seen in Janet Dorling's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Janet Dorling has not made any transactions after 2024-02-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Janet Dorling

To

Janet Dorling Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Janet Dorling owns 2 companies in total, including CymaBay Therapeutics Inc (CBAY) , and Achaogen Inc (AKAOQ) .

Click here to see the complete history of Janet Dorling’s form 4 insider trades.

Insider Ownership Summary of Janet Dorling

Ticker Comapny Transaction Date Type of Owner
CBAY CymaBay Therapeutics Inc 2024-02-12 director
AKAOQ Achaogen Inc 2019-02-21 Chief Commercial Officer

Janet Dorling Latest Holdings Summary

Janet Dorling currently owns a total of 2 stocks. Among these stocks, Janet Dorling owns 284,738 shares of Achaogen Inc (AKAOQ) as of February 21, 2019, with a value of $7,118 and a weighting of 100%. Janet Dorling also owns 0 shares of CymaBay Therapeutics Inc (CBAY) as of February 12, 2024, with a value of $0 and a weighting of 0%.

Latest Holdings of Janet Dorling

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKAOQ Achaogen Inc 2019-02-21 284,738 0.03 7,118
CBAY CymaBay Therapeutics Inc 2024-02-12 0 32.48 0

Holding Weightings of Janet Dorling


Janet Dorling Form 4 Trading Tracker

According to the SEC Form 4 filings, Janet Dorling has made a total of 0 transactions in Achaogen Inc (AKAOQ) over the past 5 years. The most-recent trade in Achaogen Inc is the sale of 1,063 shares on February 21, 2019, which brought Janet Dorling around $946.

According to the SEC Form 4 filings, Janet Dorling has made a total of 3 transactions in CymaBay Therapeutics Inc (CBAY) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in CymaBay Therapeutics Inc is the sale of 6,000 shares on February 12, 2024, which brought Janet Dorling around $191,820.

Insider Trading History of Janet Dorling

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Janet Dorling Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Janet Dorling Ownership Network

Ownership Network List of Janet Dorling

No Data

Ownership Network Relation of Janet Dorling

Insider Network Chart

Janet Dorling Owned Company Details

What does CymaBay Therapeutics Inc do?

Who are the key executives at CymaBay Therapeutics Inc?

Janet Dorling is the director of CymaBay Therapeutics Inc. Other key executives at CymaBay Therapeutics Inc include Chief Scientific Officer Charles Mcwherter , Vice President & Finance Daniel Menold , and General Counsel Paul T Quinlan .

CymaBay Therapeutics Inc (CBAY) Insider Trades Summary

Over the past 18 months, Janet Dorling made 3 insider transaction in CymaBay Therapeutics Inc (CBAY) with a net sale of 19,000. Other recent insider transactions involving CymaBay Therapeutics Inc (CBAY) include a net sale of 149,810 shares made by Charles Mcwherter , a net sale of 88,000 shares made by Paul T Quinlan , and a net sale of 52,442 shares made by Daniel Menold .

In summary, during the past 3 months, insiders sold 0 shares of CymaBay Therapeutics Inc (CBAY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 454,897 shares of CymaBay Therapeutics Inc (CBAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 454,897 shares.

CymaBay Therapeutics Inc (CBAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CymaBay Therapeutics Inc Insider Transactions

No Available Data

Janet Dorling Mailing Address

Above is the net worth, insider trading, and ownership report for Janet Dorling. You might contact Janet Dorling via mailing address: C/o Achaogen, Inc., 1 Tower Place, Suite 300, South San Francisco Ca 94080.

Discussions on Janet Dorling

No discussions yet.